The Complement System in Spondyloarthritis: What Do We Know?
نویسندگان
چکیده
Spondyloarthritis (SpA) encompasses a group of rheumatologic diseases, including axial spondyloarthritis (axSpA), psoriatic arthritis, arthritis with associated inflammatory bowel disease (i.e. Crohn’s and ulcerative colitis), reactive undifferentiated SpA, which all share certain clinical, biological genetic features. However, the pathogenesis remains largely unexplained. Recent evidence suggests an autoinflammatory component disease. The complement system is cornerstone innate immune system. This review aims to evaluate current knowledge in SpA. Animal models have shown that activation axSpA. Complement proteins L-ficolin H-ficolin levels are elevated patients axSpA, factor C3 decrease after initiation tumour necrosis factor-inhibitor therapy. Associations activity inconsistent, as one study found serum factors C4 did not differ different Bath Ankylosing Spondylitis Disease Activity Index scores but, another study, were baseline Score C-reactive protein improvement treatment inhibitor. Future studies should focus on various SpA entities, involvement progression under clinically relevant conditions.
منابع مشابه
Superior Capsule Reconstruction: What Do We Know?
The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superiorcapsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to providea comprehensive review of the available literature, in order to highlight what has so far been published on SCR,covering all aspects including biomechanica...
متن کاملMolecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.
Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...
متن کاملDiagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?
What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology
سال: 2022
ISSN: ['1462-0324', '1462-0332']
DOI: https://doi.org/10.17925/rmd.2022.1.2.50